Danone Sells Its 22.7% Stake in Lifeway Foods in $67M Secondary Public Offering

Why It Matters

The divestiture frees Danone to concentrate on core, high‑margin categories while giving Lifeway a clearer path to independent growth and governance stability. Investors will reassess earnings outlooks for both companies amid shifting strategic priorities.

Key Takeaways

• Danone exits 22.7% Lifeway stake via $19.50 secondary offering.
• Lifeway rejected Danone's 2024 takeover bids at $25–$27 per share.
• Litigation paused after board refresh deal between Danone and Lifeway.
• Lifeway's 2025 net sales hit $212.4 million, up 13.7% YoY.
• Danone will not back any board changes until June 2026.

Pulse Analysis

Danone’s decision to sell its 22.7% holding in Lifeway Foods marks a clear pivot away from a decade‑long partnership that had been marred by legal disputes and failed takeover attempts. The French multinational will offload roughly 3.45 million Lifeway shares at $19.50 each through an underwritten secondary offering, a price that reflects market sentiment rather than a premium acquisition. By exiting the position, Danone can reallocate capital toward its core portfolio of plant‑based and dairy brands that target the fast‑growing U.S. consumer segment.

For Lifeway, the transaction provides a tidy exit for Danone while delivering a modest cash infusion—about $5 million of shares earmarked for repurchase—subject to closing conditions. The company’s recent financial results, with 2025 net sales climbing to $212.4 million and Q1 2026 revenue surging 36.7% year‑over‑year, underscore strong demand for kefir and functional dairy alternatives. The board refresh agreement, which separates the chair and CEO roles, also helps stabilize governance amid a high‑profile family feud, potentially easing investor concerns.

The broader market will watch how this divestiture influences consolidation trends in the specialty dairy space. Danone’s retreat signals that large multinationals may prefer organic growth over costly acquisitions in a competitive landscape where valuation gaps, as seen in the $25‑$27 per‑share offers, can stall deals. Meanwhile, Lifeway’s ability to raise capital and improve governance positions it for independent expansion, possibly attracting new strategic partners. Analysts will likely reassess both companies’ earnings forecasts as Danone sharpens its focus on high‑margin, health‑forward product lines.

Deal Summary

Danone announced it has entered into an agreement to sell its 22.7% stake in Lifeway Foods, comprising 3.45 million shares priced at $19.50 each, in a secondary underwritten public offering expected to close on May 19, 2026. The transaction values the stake at roughly $67.4 million, with Lifeway also agreeing to repurchase about $5 million of the shares. The sale marks Danone’s exit from its long‑standing investment in the US kefir maker.